Serum Institute of India applies to DCGI to manufacture COVID-19 vaccine Sputnik V

SII to manufacture COVID-19 vaccine Sputnik V from September, announces RDIF

In an order to boost the COVID-19 vaccination in India, the Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Russian COVID-19 vaccine Sputnik V in the country.

The Pune-based Serum Institute of India has also sought approval for test analysis and examination. The Russian COVID-19 vaccine Sputnik V is currently being manufactured in India by Dr Reddy’s Laboratories.

Also Read | Myths and Facts of COVID-19 vaccination in India; here is what PM Modi govt doing to vaccinate Indians

 COVID-19 vaccination in India: Serum Institute of India applied to DCGI seeking permission to manufacture COVID-19 vaccine Sputnik V in India.

As per the sources, the SII has put up an application to DCGI on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India.

Also Read | Third wave of coronavirus in Maharashtra? Over 8,000 children test positive in 1 district

 COVID-19 vaccination in India: Serum Institute of India applied to DCGI seeking permission to manufacture COVID-19 vaccine Sputnik V in India.

The SII told the government that it will be able to manufacture and supply over 10 crore doses of Covishield in June.

 COVID-19 vaccination in India: Serum Institute of India applied to DCGI seeking permission to manufacture COVID-19 vaccine Sputnik V in India.

It said that it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.

Sputnik was given emergency use authorisation (EUA) by the DCGI in April while a consignment of 30 lakh doses arrived in Hyderabad on Tuesday.

Click here to follow PTC News on Twitter

-PTC News